• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday

    5/29/24 10:38:24 AM ET
    $ANF
    $ASTS
    $BOX
    $DKS
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Telecommunications Equipment
    Consumer Discretionary
    Get the next $ANF alert in real time by email

    U.S. stocks were lower, with the Dow Jones index falling more than 300 points on Wednesday.

    Shares of HEICO Corporation (NYSE:HEI) rose sharply during Wednesday's session following a second-quarter earnings beat.

    Heico posted quarterly GAAP earnings of 88 cents per share, beating market estimates of 81 cents per share. The company's quarterly sales came in at $955.395 million versus expectations of $951.206 million, according to data from Benzinga Pro.

    HEICO shares gained 4.6% to $221.76 on Wednesday.

    Here are some other big stocks recording gains in today's session.

    • AST SpaceMobile, Inc. (NASDAQ:ASTS) shares gained 29% to $6.88 after the company announced a partnership with Verizon for direct-to-cellular AST SpaceMobile service when needed for Verizon customers.
    • Ooma, Inc. (NYSE:OOMA) gained 22.3% to $9.66 after the company reported better-than-expected first-quarter financial results and issued strong guidance for the second quarter.
    • SOPHiA GENETICS SA (NASDAQ:SOPH) gained 21.1% to $5.96.
    • Surmodics, Inc. (NASDAQ:SRDX) climbed 20.3% to $42.23 after the company announced it will be acquired by GTCR for $43 per share in cash for a total equity valuation of roughly $627 million.
    • Abercrombie & Fitch Co. (NYSE:ANF) shares rose 15.9% to $176.57 following better-than-expected first-quarter financial results.
    • DICK’S Sporting Goods, Inc. (NYSE:DKS) gained 15.8% to $225.87 as the company reported better-than-expected first-quarter FY24 earnings and raised the outlook.
    • Semler Scientific, Inc. (NASDAQ:SMLR) surged 14.8% to $33.28. The company recenyly announced that its board of directors adopted bitcoin as its primary treasury reserve asset.
    • Gyre Therapeutics, Inc. (NASDAQ:GYRE) jumped 12.3% to $11.40. Gyre Therapeutics announced expected addition to the Russell 2000® and Russell 3000® Indexes.
    • Immunovant, Inc. (NASDAQ:IMVT) gained 11.3% to $31.66.
    • Hello Group Inc. (NASDAQ:MOMO) jumped 9.8% to $5.32.
    • Marathon Oil Corporation (NYSE:MRO) jumped 9.6% to $29.00 after ConocoPhillips announced it will acquire the company.
    • Box, Inc. (NYSE:BOX) jumped 9.1% to $27.30 as the company reported its first-quarter financial results.
    • N-able, Inc. (NASDAQ:NABL) gained 9% to $13.74 following a report suggesting the company is running a sale process amid takeover interest.
    • Titan Machinery Inc. (NASDAQ:TITN) rose 8.2% to $19.18.
    • Daqo New Energy Corp. (NYSE:DQ) gained 8% to $21.53.
    • JinkoSolar Holding Co., Ltd. (NYSE:JKS) jumped 4.9% to $29.78.

    Now Read This: Amazon, Target, Diamondback Energy And More On CNBC’s ‘Final Trades‘

    Get the next $ANF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANF
    $ASTS
    $BOX
    $DKS

    CompanyDatePrice TargetRatingAnalyst
    Abercrombie & Fitch Company
    $ANF
    3/26/2026$108.00Buy
    Needham
    JinkoSolar Holding Company Limited
    $JKS
    3/24/2026$28.50Sell → Buy
    Daiwa Securities
    N-able Inc.
    $NABL
    3/23/2026Outperform → Underperform
    William Blair
    Box Inc.
    $BOX
    3/23/2026Outperform → Mkt Perform
    William Blair
    Immunovant Inc.
    $IMVT
    3/20/2026$28.00Mkt Perform
    Bernstein
    Heico Corporation
    $HEI
    2/27/2026Neutral → Outperform
    BNP Paribas Exane
    N-able Inc.
    $NABL
    2/20/2026$9.50 → $5.50Market Perform
    BMO Capital Markets
    N-able Inc.
    $NABL
    1/23/2026$10.00Buy
    B. Riley Securities
    More analyst ratings

    $ANF
    $ASTS
    $BOX
    $DKS
    SEC Filings

    View All

    SEC Form 10-K filed by Ooma Inc.

    10-K - OOMA INC (0001327688) (Filer)

    4/3/26 5:23:10 PM ET
    $OOMA
    EDP Services
    Technology

    SEC Form 10-K filed by Titan Machinery Inc.

    10-K - Titan Machinery Inc. (0001409171) (Filer)

    3/31/26 4:07:15 PM ET
    $TITN
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 10-K filed by Dick's Sporting Goods Inc

    10-K - DICK'S SPORTING GOODS, INC. (0001089063) (Filer)

    3/27/26 5:22:05 PM ET
    $DKS
    Other Specialty Stores
    Consumer Discretionary

    $ANF
    $ASTS
    $BOX
    $DKS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Venker Eric

    4 - Immunovant, Inc. (0001764013) (Issuer)

    4/3/26 4:33:01 PM ET
    $IMVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Larsen Robert

    4 - Titan Machinery Inc. (0001409171) (Issuer)

    4/3/26 10:40:47 AM ET
    $TITN
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Knutson Bryan J

    4 - Titan Machinery Inc. (0001409171) (Issuer)

    4/3/26 10:39:20 AM ET
    $TITN
    Other Specialty Stores
    Consumer Discretionary

    $ANF
    $ASTS
    $BOX
    $DKS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Abercrombie & Fitch with a new price target

    Needham initiated coverage of Abercrombie & Fitch with a rating of Buy and set a new price target of $108.00

    3/26/26 8:44:16 AM ET
    $ANF
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    JinkoSolar upgraded by Daiwa Securities with a new price target

    Daiwa Securities upgraded JinkoSolar from Sell to Buy and set a new price target of $28.50

    3/24/26 8:27:29 AM ET
    $JKS
    Semiconductors
    Technology

    N-able downgraded by William Blair

    William Blair downgraded N-able from Outperform to Underperform

    3/23/26 8:27:27 AM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    $ANF
    $ASTS
    $BOX
    $DKS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Only Mach 2+ Commercial Fleet in the World Is Now Testing Reusable Hypersonic Space Systems -- and the Pentagon Is Writing the Checks

    Issued on behalf of Starfighters Space, Inc.CAPE CANAVERAL, Fla., April 2, 2026 /CNW/ -- USA News Group News Commentary — The next arms race isn't being fought on the ground. It's being fought at 45,000 feet and Mach 2, in the stratosphere where hypersonic weapons are validated, reusable space systems are tested, and the gap between the United States and its adversaries is either closed or conceded. The Pentagon knows it. Congress knows it. And the capital flowing into the commercial aerospace sector right now reflects exactly that urgency. The U.S. Space Force is operating on a

    4/2/26 2:02:00 PM ET
    $ASTS
    $FJET
    $LUNR
    Telecommunications Equipment
    Consumer Discretionary
    Air Freight/Delivery Services
    Industrial Machinery/Components

    N‑able Expands Its Technology Alliance Program with New Integrations, Advancing Incident Response and Hyperautomation

    New integrations empower MSPs and customers to automate complex security workflows and accelerate recovery from ransomware attacks N-able, Inc. (NYSE:NABL), a global cybersecurity company delivering business resilience, today announced new additions to its Technology Alliance Program (TAP), Zensec and Atomatik. The N‑able Technology Alliance Program is a strategic initiative that brings together industry-leading technology companies to build deeper, more secure integrations across N‑able's award‑winning business resilience platform—enabling scalable collaboration and delivering greater flexibility and value for vendors and customers worldwide. As IT environments grow more complex and

    4/2/26 6:00:00 AM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

    Phase 3 studies of batoclimab in thyroid eye disease (TED) each failed to meet their primary endpoint; safety results were consistent with previous findingsPatients in the TED studies demonstrated greater levels of proptosis improvement from baseline after the initial 12-week high-dose period than after the following 12-week low-dose period, supporting the benefit of deeper IgG suppression. The hyperthyroid patients in the TED studies showed similar response rates of thyroid hormone normalization to those seen in the batoclimab Phase 2 study in Graves' diseaseImmunovant remains focused on rapid advancement of IMVT-1402 in multiple indications DURHAM, N.C., April 02, 2026 (GLOBE NEWSWIRE)

    4/2/26 5:00:00 AM ET
    $IMVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ANF
    $ASTS
    $BOX
    $DKS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Larson Keith R bought $50,000 worth of shares (625 units at $80.00) (SEC Form 4)

    4 - AST SpaceMobile, Inc. (0001780312) (Issuer)

    12/29/25 6:00:02 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Director Larson Keith R bought $50,064 worth of shares (715 units at $70.02) (SEC Form 4)

    4 - AST SpaceMobile, Inc. (0001780312) (Issuer)

    12/17/25 6:00:10 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Director Roivant Sciences Ltd. bought $349,999,986 worth of shares (16,666,666 units at $21.00), increasing direct ownership by 17% to 113,317,007 units (SEC Form 4)

    4 - Immunovant, Inc. (0001764013) (Issuer)

    12/12/25 5:17:21 PM ET
    $IMVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ANF
    $ASTS
    $BOX
    $DKS
    Leadership Updates

    Live Leadership Updates

    View All

    Strive Announces the Completion of Semler Scientific Acquisition

    DALLAS, TX, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST) ("Strive") today announced the successful completion of the previously announced acquisition of Semler Scientific. Strive now holds approximately 12,797.9 bitcoin, becoming the #11 largest public corporate holder of bitcoin globally. Strive also announces the appointment of Avik Roy as Chief Strategy Officer of Strive. Mr. Roy's initial focus will be on Strive's intentions to monetize the operating business from the Semler Scientific subsidiary by expanding its mandate in early disease detection products.  Mr. Roy began his career in science at MIT and trained as a physician at Yale Medical School before joining Ba

    1/16/26 8:40:00 AM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    N-able Appoints Patrick Pulvermueller to Board of Directors

    Appointment expands board's strategic depth as the company accelerates cyber resilience innovation N-able (NYSE:NABL), a global software company delivering an end-to-end cyber resilience platform, today announced the appointment of Patrick Pulvermueller as a member of the board of directors. Pulvermueller joins N-able as the company continues to strengthen its leadership team and accelerate its mission to empower organizations to stay secure and resilient in business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108588163/en/Patrick Pulvermueller Pulvermueller brings decades of experience in technology leadership and cybe

    1/8/26 6:00:00 AM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    JinkoSolar Announces Results of 2025 Annual General Meeting

    SHANGRAO, China, Dec. 29, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE:JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that all shareholders resolutions proposed at the Company's 2025 annual general meeting held today were duly passed. Specifically, the Company's shareholders passed the following ordinary resolutions approving: The re-election of Mr. Haiyun Cao as a director of the Company;The re-election of Mr. Wing Keong Siew as an independent director of the Company;The ratification of the appointment of PricewaterhouseCoopers Zhong Tian LLP as auditors of the Company for the fiscal year of 2

    12/29/25 12:13:00 AM ET
    $JKS
    Semiconductors
    Technology

    $ANF
    $ASTS
    $BOX
    $DKS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    12/12/24 4:16:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by Semler Scientific Inc.

    SC 13G - Semler Scientific, Inc. (0001554859) (Subject)

    11/26/24 12:09:40 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by AST SpaceMobile Inc.

    SC 13D/A - AST SpaceMobile, Inc. (0001780312) (Subject)

    11/20/24 9:59:14 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    $ANF
    $ASTS
    $BOX
    $DKS
    Financials

    Live finance-specific insights

    View All

    The Only Mach 2+ Commercial Fleet in the World Is Now Testing Reusable Hypersonic Space Systems -- and the Pentagon Is Writing the Checks

    Issued on behalf of Starfighters Space, Inc.CAPE CANAVERAL, Fla., April 2, 2026 /CNW/ -- USA News Group News Commentary — The next arms race isn't being fought on the ground. It's being fought at 45,000 feet and Mach 2, in the stratosphere where hypersonic weapons are validated, reusable space systems are tested, and the gap between the United States and its adversaries is either closed or conceded. The Pentagon knows it. Congress knows it. And the capital flowing into the commercial aerospace sector right now reflects exactly that urgency. The U.S. Space Force is operating on a

    4/2/26 2:02:00 PM ET
    $ASTS
    $FJET
    $LUNR
    Telecommunications Equipment
    Consumer Discretionary
    Air Freight/Delivery Services
    Industrial Machinery/Components

    Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

    Phase 3 studies of batoclimab in thyroid eye disease (TED) each failed to meet their primary endpoint; safety results were consistent with previous findingsPatients in the TED studies demonstrated greater levels of proptosis improvement from baseline after the initial 12-week high-dose period than after the following 12-week low-dose period, supporting the benefit of deeper IgG suppression. The hyperthyroid patients in the TED studies showed similar response rates of thyroid hormone normalization to those seen in the batoclimab Phase 2 study in Graves' diseaseImmunovant remains focused on rapid advancement of IMVT-1402 in multiple indications DURHAM, N.C., April 02, 2026 (GLOBE NEWSWIRE)

    4/2/26 5:00:00 AM ET
    $IMVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    JinkoSolar to Report Fourth Quarter and Full Year 2025 Results on April 16, 2026

    SHANGRAO, China, March 24, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE:JKS), a global leader in clean energy technology, today announced that it plans to release its unaudited financial results for the fourth quarter and full year ended December 31, 2025 before the open of U.S. markets on Thursday, April 16, 2026. JinkoSolar's management will host an earnings conference call on Thursday, April 16, 2026 at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing / Hong Kong the same day).Please register in advance of the conference using the link provided below. Upon registering, you will be provided with participant dial-in numbers, passcode and unique acces

    3/24/26 6:00:00 AM ET
    $JKS
    Semiconductors
    Technology